World Lung Foundation

Last updated
World Lung Foundation
Founded2004
Focus Public Health
Location
Area served
Worldwide
Services Health Communications, Capacity Building, Project Management, Education, Operational Research
Key people
Peter Baldini, Judith Mackay, Neil Schluger, Sandra Mullin

World Lung Foundation (WLF) is a non-profit foundation established in 2004 to support private organizations and government agencies, who work to improve lung health, predominantly in low- and middle-income countries.

Contents

WLF provides financial and technical assistance to governments and non-government organizations in four priority areas: Health Communications and Information, Capacity Building, Project Management, and Operational Research. These projects are in the following lung health areas: tobacco control, asthma, and tuberculosis. The organization also works on maternal health initiatives.

Activities

WLF Projects WLF supports include:

Research

Public health policy

Capacity building

Public health education

Offices and locations

Headquarters

New York City

Team based

Beijing, Dar Es Salaam, Delhi, The Hague, Hong Kong, Melbourne, Moscow, Paris, Sydney, Egypt

Project locations

Afghanistan, Bangladesh, Colombia, Brazil, China, Egypt, India, Indonesia, Kenya, Mauritius, Mexico, Pakistan, Philippines, Poland, Russia, Tanzania, Thailand, Turkey, Ukraine, and Vietnam.

Recent projects

Bloomberg Initiative

WLF is a partner in the Bloomberg Initiative to Reduce Tobacco Use, funded by Bloomberg Philanthropies and, more recently, the Bill and Melinda Gates Foundation. [1] The goal of the Initiative is to reduce tobacco use in low- and middle-income countries, where 80% of the 6 million deaths resulting from tobacco use took place in 2011. [2] WLF = funds and supports mass media ad campaigns on the harmful effects of smoking and other forms of tobacco use. WLF has supported 80 tobacco control mass media campaigns in 20 countries. WLF disbursed millions from Bloomberg Philanthropies and the Bill and Melinda Gates Foundation to The International Union against Tuberculosis and Lung Disease (The Union), the World Health Organization, the Framework Convention Alliance, and the CDC Foundation to strengthen their tobacco control activities and to support its own mass media programs. Other partners in the Bloomberg Initiative are Campaign for Tobacco-Free Kids and the Johns Hopkins University Bloomberg School of Public Health.

Maternal health

With financial support from Bloomberg Philanthropies, WLF has implemented an emergency maternal health obstetrics program in the Kigoma, Morogoro, and Pwani provinces of Tanzania. The program has trained 50 non-physician clinicians to deliver babies via cesarian section if needed, and midwives to assist in obstetrics care. In addition, WLF has renovated twelve rural health care centers and upgraded five district hospitals. This includes building three new maternity wards and operating theatres that are fully equipped with surgical equipment and reliable supplies of electricity and clean water. 26 staff houses have also been built.

TB Center

WLF helped fund Asia's first International Tuberculosis Center, which opened in Manila in 2008. The facility provides treatment, research, training and a steady supply of medications to combat Multi-Drug Resistant TB (MDR-TB) in the Philippines and across Asia. Since the opening of the center, dozens of clinicians from around the world have been trained on the best prevention, diagnosis and treatment techniques for MDR-TB.[ citation needed ]

Advocacy resources

The Tobacco Atlas, Fourth Edition

The Tobacco Atlas is a compendium of research on tobacco use.

Multimedia resources

World Lung Foundation offers multimedia resources online to assist low and middle income countries interested in creating their own cessation and smoke-free ad campaigns.

15000aDay.org

15000aDay.org is a website where advocates can support tobacco control policies.

Acute Respiratory Infections Atlas, First Edition

The Acute Respiratory Infections Atlas is a compendium of research on acute respiratory infections such as pneumonia, influenza, and respiratory syncytial virus (RSV).

Available publications

Tahir Turk, PhD1; Nandita Murukutla, PhD1, Shefali Gupta, MA1, JagdishKaur, MD2; Sandra Mullin, MSW1, RanjanaSaradhi, MSW3, Pankaj Chaturvedi, MD4 (2012). Using a smokeless tobacco control mass media campaign and other synergistic elements to address social inequalities in India. Cancer Causes and Control, 23(0), 81–90. doi: 10.1007/s10552-012-9903-3

Alday J, Murukutla N, Cedillo C, et al. Smoke-free S ̃ao Paulo: a campaign evaluation and the case for sustained mass media investment. Salud P ́ublica de M ́ex 2010;52 (suppl 2):S216eS25. Mullin, S. Global anti-smoking campaigns urgently needed, The Lancet, Online First July 8

Mullin, S, Prasad, V., Kaur. J., Turk, T. Increasing Evidence for the Efficacy of Tobacco Control Mass Media Communication Programming in Low- and Middle-Income Countries, J of Health Communication, vol. 16, supplement 2, 2011

Mullin, S. Chapter 13 Risk and Crisis Communication: Practical Advice for Responding to Mass Fatality Events. Death in Large Numbers, The Science, Policy and Management of Mass Fatality Events, Gursky, E, Farinelli, M, editors. publisher AMA, 2012.

Murukutla, N., Turk, T., Prasad, C.V.S., Saradhi, R., Kaur, J., Gupta, S., Mullin, S., Ram, F., Gupta, P., Wakefield, M. (2011) Results of a national mass media campaign in India to warn against the dangers of smokeless tobacco consumption. Tobacco Control 2011; tc.2010.039438Published Online First: 20 April 2011 doi:10.1136/tc.2010.039438

Perl, R., Stebenkova, L., Morozova, I., Murukutla, N., Kochetova, V., Kotov, A., Voylokova, T., Baskakova, J. (October 2011). Mass media campaigns within reach: effective efforts with limited resources in Russia's capital city. Tobacco Control 2011;20:439-441 Published Online First: 18 June 2011 doi:10.1136/tc.2010.041269

Thrasher, J.F., Huang, L., Pérez-Hernández, R., Niederdeppe, J., Arillo-Santillán, E., Alday, J. (Feb. 2011) Evaluation of a social marketing campaign to support Mexico City's comprehensive smoke-free law. Am J Public Health;101(2):328-35.

Thrasher, J.F., Murukutla, N., Pérez-Hernández, R., Alday, J., Arillo-Santillán, E., Cedillo C, Gutierrez, J.P. (Under review). Linking mass media campaigns to pictorial warning labels on cigarette packages: An evaluation of impacts among Mexican smokers.

Turk, T., Murukutla, N., Gupta, S., Kaur, J., Mullin, S., Saradhi, R. (Under review). Addressing social inequalities in smokeless tobacco consumption through the implementation of a social marketing campaign and other synergistic elements in India.

Wakefield, M., Bayly, M., Durkin, S., Cotter, T., Mullin, S., Warne, C., for the International Anti-Tobacco Advertisement Rating Study Team. Smokers' responses to television advertisements about the serious harms of tobacco use: pre-testing results from 10 low- to middle-income countries. Tob Control 2011;tobaccocontrol-2011-050171Published Online First: 12 October 2011 doi:10.1136/tobaccocontrol-2011-050171

Related Research Articles

<span class="mw-page-title-main">Tuberculosis</span> Infectious disease

Tuberculosis (TB), also known colloquially as the "white death", or historically as consumption, is an infectious disease usually caused by Mycobacterium tuberculosis (MTB) bacteria. Tuberculosis generally affects the lungs, but it can also affect other parts of the body. Most infections show no symptoms, in which case it is known as latent tuberculosis. Around 10% of latent infections progress to active disease which, if left untreated, kill about half of those affected. Typical symptoms of active TB are chronic cough with blood-containing mucus, fever, night sweats, and weight loss. Infection of other organs can cause a wide range of symptoms.

<span class="mw-page-title-main">Snus</span> Moist tobacco product placed under the upper lip

Snus is a tobacco product, originating from a variant of dry snuff in early 18th-century Sweden. It is placed between the upper lip and gum for extended periods, as a form of sublabial administration. Snus is not fermented. Although used similarly to American dipping tobacco, snus does not typically result in the need for spitting and, unlike naswar, snus is steam-pasteurized.

<span class="mw-page-title-main">Chewing tobacco</span> Type of smokeless tobacco product

Chewing tobacco is a type of smokeless tobacco product that is placed between the cheek and lower gum to draw out its flavor. It consists of coarsely chopped aged tobacco that is flavored and often sweetened; it is not ground fine like dipping tobacco. Unwanted juices are then spat.

<span class="mw-page-title-main">Nicotine marketing</span> Marketing technique

Nicotine marketing is the marketing of nicotine-containing products or use. Traditionally, the tobacco industry markets cigarette smoking, but it is increasingly marketing other products, such as electronic cigarettes and heated tobacco products. Products are marketed through social media, stealth marketing, mass media, and sponsorship. Expenditures on nicotine marketing are in the tens of billions a year; in the US alone, spending was over US$1 million per hour in 2016; in 2003, per-capita marketing spending was $290 per adult smoker, or $45 per inhabitant. Nicotine marketing is increasingly regulated; some forms of nicotine advertising are banned in many countries. The World Health Organization recommends a complete tobacco advertising ban.

<span class="mw-page-title-main">Smokeless tobacco</span> Tobacco product used by means other than smoking.

Smokeless tobacco is a tobacco product that is used by means other than smoking. Their use involves chewing, sniffing, or placing the product between gum and the cheek or lip. Smokeless tobacco products are produced in various forms, such as chewing tobacco, snuff, snus, and dissolvable tobacco products. Smokeless tobacco products typically contain over 3000 constituents. All smokeless tobacco products contain nicotine and are therefore highly addictive. Quitting smokeless tobacco use is as challenging as smoking cessation.

<span class="mw-page-title-main">Snuff (tobacco)</span> Smokeless tobacco type

Snuff is a type of smokeless tobacco product made from finely ground or pulverized tobacco leaves. It is snorted or "sniffed" into the nasal cavity, delivering nicotine and a flavored scent to the user. Traditionally, it is sniffed or inhaled lightly after a pinch of snuff is either placed onto the back surface of the hand, held pinched between thumb and index finger, or held by a specially made "snuffing" device.


Tobacco harm reduction (THR) is a public health strategy to lower the health risks to individuals and wider society associated with using tobacco products. It is an example of the concept of harm reduction, a strategy for dealing with the use of drugs. Tobacco smoking is widely acknowledged as a leading cause of illness and death, and reducing smoking is vital to public health.

<span class="mw-page-title-main">Electronic cigarette</span> Device that vaporizes a liquid nicotine solution for inhalation

An electronic cigarette (e-cigarette) or vape is a device that simulates tobacco smoking. It consists of an atomizer, a power source such as a battery, and a container such as a cartridge or tank filled with liquid. Instead of smoke, the user inhales vapor. As such, using an e-cigarette is often called "vaping". The atomizer is a heating element that vaporizes a liquid solution called e-liquid, which quickly cools into an aerosol of tiny droplets, vapor and air. E-cigarettes are activated by taking a puff or pressing a button. Some look like traditional cigarettes, and most kinds are reusable. The vapor mainly comprises propylene glycol and/or glycerin, usually with nicotine and flavoring. Its exact composition varies, and depends on several things including user behavior.

<span class="mw-page-title-main">Flavored tobacco</span> Tobacco product with added flavorings

Flavored tobacco products — tobacco products with added flavorings — include types of cigarettes, cigarillos and cigars, hookahs and hookah tobacco, various types of smokeless tobacco, and more recently electronic cigarettes. Flavored tobacco products are especially popular with youth and have therefore become targets of regulation in several countries.

Tobacco-specific nitrosamines (TSNAs) comprise one of the most important groups of carcinogens in tobacco products, particularly cigarettes and fermented dipping snuff.

Respiratory Health Association is a nonprofit organization located on Chicago's Near West Side.

<span class="mw-page-title-main">Cigarette taxes in the United States</span> Taxes imposed on sale of cigarettes in the U.S.

In the United States, cigarettes are taxed at both the federal and state levels, in addition to any state and local sales taxes and local cigarette-specific taxes. Cigarette taxation has appeared throughout American history and is still a contested issue today.

<span class="mw-page-title-main">Judith Mackay</span>

Judith Longstaff Mackay, SBS, OBE, JP, FRCP (Edin), FRCP (Lon) is a British-born and Hong Kong–based medical doctor and international tobacco control advocate who has led a campaign against tobacco in Asia from 1984 onwards, campaigning for tax increases to discourage youth smoking, for the creation of smoke-free areas, and against tobacco promotion. Her main interests are tobacco in low-income countries, women and tobacco, and challenging the transnational tobacco companies.

Tobacco is an agricultural product acting as a stimulant triggering complex biochemical and neurotransmitter disruptions. Its main ingredient is nicotine and it is present in all cigarettes. Early tobacco usage was for medical cures and religious purposes. In the early 1900s, cigarette usage became increasingly popular when it was sold in mass amounts. In 1964, the Surgeon General of the United States wrote a report concerning the dangers of cigarette smoking. In the United States, for the past 50 years efforts have been made so that the public should be aware of the risks of tobacco usage.

The International Union Against Tuberculosis and Lung Disease, or The Union, is a century old global membership based, scientific organization headquartered in Paris with the stated goals to "improve health for people in low- and middle-income Countries". The Union focuses its work in three areas of lung health: Tuberculosis control, Tobacco Control, and other communicable and non-communicable Lung diseases.The Union organises the annual Union World Conference on Lung Health, the largest annual meeting on lung health in the world, manages the International Journal of TB and Lung Disease, and implements various funded projects and activities across the world.

MPOWER is a policy package intended to assist in the country-level implementation of effective interventions to reduce the demand for tobacco, as ratified by the World Health Organization (WHO) Framework Convention on Tobacco Control. The six evidence-based components of MPOWER are:

A heated tobacco product (HTP) is a tobacco product that heats the tobacco at a lower temperature than conventional cigarettes. These products contain nicotine, which is a highly addictive chemical. The heat generates an aerosol or smoke to be inhaled from the tobacco, which contains nicotine and other chemicals. HTPs may also contain additives not found in tobacco, including flavoring chemicals. HTPs generally heat tobacco to temperatures under 600 °C (1100 °F), a lower temperature than conventional cigarettes.

<span class="mw-page-title-main">Iqos</span> Heated tobacco products by Philip Morris International

Iqos is a line of heated tobacco and electronic cigarette products manufactured by Philip Morris International (PMI). It was first introduced in November 2014 in Japan and Italy. Most of the IQOS products are devices that heat tobacco without burning it.

The Foundation for a Smoke-Free World is an organization focused on smoking harm reduction founded in 2017. It is funded by Philip Morris International (PMI), which had initial plans for $80 million in annual funding. The current pledge agreement from PMI to the Foundation, modified in September 2020, promises $35 million in funding to the Foundation from 2022 through 2029.

The composition of the emissions generated from heated tobacco products are generally lower than that found in cigarette smoke. This is due to the comparatively low temperatures, the filter systems, and physical design. The composition of what is produced is complex. The main toxicants found in the emissions of cigarette smoke are also found in the emissions of these products in varying concentrations. The aerosol generated contains levels of nicotine and cancer-causing chemicals that are comparable to regular cigarettes. The emissions contained 84% of the nicotine found in regular cigarettes.

References

  1. ↑ "Billionaires Back Antismoking Effort (Published 2008)". The New York Times .
  2. ↑ Mackay, Judith (25 February 2022). "The Tobacco Atlas". Fourth Edition. American Cancer Society.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.